Angelo Pan

4.9k citations
123 papers · 3.8k · 2 hit papers · h-index 30

Impact in

    • Antibiotic Use and Resistance
    • COVID-19 Clinical Research Studies
    • Infection Control in Healthcare
    • HIV/AIDS drug development and treatment
    • Antimicrobial Resistance in Staphylococcus
    • SARS-CoV-2 and COVID-19 Research

Papers in

Angelo Pan

112 papers receiving 3.6k citations

Angelo Pan's Hit Papers

Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses 2022 · 290 citations
2900+4+8Years since publication200400600

Peers

Angelo Pan
Comparison fields: 5 of 133
  • Applied Microbiology and Biotechnology 369
  • Infectious Diseases 1.7k
  • Molecular Medicine 534
  • Virology 128
  • Internal Medicine 80
Replace Miguel Salavert with:
Miguel Salavert Spain
Hee Jin Cheong South Korea
Christian Rabaud France
Carlo Torti Italy
Pascal Astagneau France
Emanuele Durante‐Mangoni Italy
Juan Ambrosioni Spain
Carlos Lumbreras Spain
Enrico Maria Trecarichi Italy
Roberto Luzzati Italy
Angelo Pan relative to Miguel Salavert Spain Miguel Salavert's profile →
Citations per field
00.5×5×10×13.3×
Miguel Salavert · 1×
Citations per year

Countries citing papers authored by Angelo Pan

Since Specialization
Citations

This map shows the geographic impact of Angelo Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angelo Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angelo Pan more than expected).

Fields of papers citing papers by Angelo Pan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angelo Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angelo Pan. The network helps show where Angelo Pan may publish in the future.

Co-authors

The 25 scholars most cited alongside Angelo Pan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Angelo Pan Line = papers co-authored together Angelo Pan links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 123 papers — load more, or switch the sort, to bring in the rest.

#Work
1
ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients
Hit paper breakdown →
2013706
2
Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses
Hit paper breakdown →
2022290
3 2016172
4 2020135
5 2020132
6 2009123
7 2018112
8 2021110
9 2002102
10 201481
11 200880
12 202066
13 200562
14 201462
15 202361
16 202058
17 200255
18 200050
19 201349
20 201546

About Angelo Pan

Angelo Pan is a scholar working on Infectious Diseases, Applied Microbiology and Biotechnology, Hepatology, Virology and Emergency Medicine, having authored 123 papers that have together received 3.8k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (27 papers), Antimicrobial Resistance in Staphylococcus (14 papers), Hepatitis C virus research (12 papers), Antibiotic Use and Resistance (12 papers), COVID-19 Clinical Research Studies (11 papers), Infection Control in Healthcare (9 papers), HIV Research and Treatment (8 papers) and HIV-related health complications and treatments (8 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (369 citations), Infectious Diseases (1.7k citations), Molecular Medicine (534 citations), Virology (128 citations) and Internal Medicine (80 citations). Angelo Pan has collaborated with scholars based in Italy, Spain and Germany. Frequent co-authors include Evelina Tacconelli, Maria Adriana Cataldo, Marco Falcone, Giulia De Angelis, Nicola Petrosillo, Stephanie J. Dancer, Uwe Frank, Jesús Rodríguez‐Baño, Gunnar Kahlmeter and Mario Venditti. Their work appears in journals such as Journal of Antimicrobial Chemotherapy, Digestive and Liver Disease, Journal of Hepatology, AIDS and Infection Control and Hospital Epidemiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact